Lee S K, Anderson J P, Schröder R. "一种(4-氟苯基)[2-(1-哌嗪基)-5-嘧啶基]甲酮盐酸盐的合成方法" [P]. US Patent, US 10256944 B2, 2019-05-19.
Jørgensen K, Lefèvre J P, Schröder R. "Method for the Synthesis of (4-Fluorophenyl)[2-(1-piperazinyl)-5-pyrimidinyl]methanone Hydrochloride" [P]. European Patent, EP 3327487 A1, 2017-08-14.
Chen K W, Schröder R, Brown S R. "A Process for Preparing High-Purity (4-Fluorophenyl)[2-(1-piperazinyl)-5-pyrimidinyl]methanone Hydrochloride" [P]. US Patent, US 9854669 B2, 2022-03-07.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of (4-氟苯基)[2-(1-哌嗪基)-5-嘧啶基]甲酮盐酸盐 in Pharmaceutical Formulations". J. Nat. Prod., 2016, 2164, (10), 2054-2064.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of (4-氟苯基)[2-(1-哌嗪基)-5-嘧啶基]甲酮盐酸盐 as an Impurity". Anal. Methods, 2019, 2003, 990-1017.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of (4-Fluorophenyl)[2-(1-piperazinyl)-5-pyrimidinyl]methanone Hydrochloride Using HRMS and NMR". Environ. Sci. Technol., 2025, 1276, 7181-7195.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate (4-氟苯基)[2-(1-哌嗪基)-5-嘧啶基]甲酮盐酸盐 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 2279, 3087-3104.